Bridger Management as of Sept. 30, 2011
Portfolio Holdings for Bridger Management
Bridger Management holds 45 positions in its portfolio as reported in the September 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| CareFusion Corporation | 8.2 | $110M | 4.6M | 23.95 | |
| 7.2 | $97M | 189k | 515.04 | ||
| Las Vegas Sands (LVS) | 6.1 | $82M | 2.2M | 38.34 | |
| Morgan Stanley (MS) | 5.8 | $79M | 5.8M | 13.51 | |
| Directv | 5.7 | $76M | 1.8M | 42.27 | |
| General Motors Company (GM) | 5.6 | $75M | 3.7M | 20.18 | |
| Apple (AAPL) | 5.4 | $73M | 190k | 381.32 | |
| United Rentals (URI) | 5.2 | $70M | 4.2M | 16.84 | |
| Hyatt Hotels Corporation (H) | 4.2 | $57M | 1.8M | 31.37 | |
| Hca Holdings (HCA) | 3.7 | $50M | 2.5M | 20.16 | |
| Cott Corp | 3.3 | $45M | 6.6M | 6.81 | |
| Assured Guaranty (AGO) | 3.3 | $45M | 4.1M | 10.99 | |
| Starwood Hotels & Resorts Worldwide | 3.1 | $42M | 1.1M | 38.82 | |
| Bristol Myers Squibb (BMY) | 3.1 | $42M | 1.3M | 31.38 | |
| Allergan | 2.8 | $38M | 456k | 82.38 | |
| Onyx Pharmaceuticals | 2.4 | $32M | 1.1M | 30.01 | |
| Avis Budget (CAR) | 2.2 | $30M | 3.1M | 9.67 | |
| Charles River Laboratories (CRL) | 2.1 | $28M | 970k | 28.62 | |
| Pharmasset | 1.8 | $24M | 290k | 82.37 | |
| Wright Medical | 1.6 | $22M | 1.2M | 17.88 | |
| BP (BP) | 1.5 | $21M | 575k | 36.07 | |
| Ironwood Pharmaceuticals (IRWD) | 1.5 | $20M | 1.9M | 10.80 | |
| Acorda Therapeutics | 1.3 | $17M | 850k | 19.96 | |
| PennyMac Mortgage Investment Trust (PMT) | 1.2 | $17M | 1.1M | 15.90 | |
| MAKO Surgical | 1.0 | $14M | 400k | 34.22 | |
| K12 | 1.0 | $13M | 522k | 25.46 | |
| Anadarko Petroleum Corporation | 0.9 | $12M | 187k | 63.05 | |
| Orchid Cellmark | 0.8 | $11M | 4.0M | 2.68 | |
| iStar Financial | 0.8 | $10M | 1.8M | 5.82 | |
| Cardiome Pharma Corp | 0.7 | $9.6M | 2.9M | 3.29 | |
| Casella Waste Systems (CWST) | 0.7 | $9.4M | 1.8M | 5.26 | |
| HiSoft Technology International (HSFT) | 0.7 | $8.7M | 992k | 8.79 | |
| Inhibitex | 0.6 | $8.6M | 3.5M | 2.46 | |
| Popular | 0.6 | $8.4M | 5.6M | 1.50 | |
| Anthera Pharmaceuticals | 0.6 | $7.8M | 1.6M | 4.77 | |
| Pharmacyclics | 0.5 | $7.1M | 602k | 11.83 | |
| Boston Beer Company (SAM) | 0.5 | $6.6M | 91k | 72.70 | |
| Dollar Thrifty Automotive | 0.4 | $5.6M | 100k | 56.30 | |
| MAP Pharmaceuticals | 0.4 | $5.5M | 378k | 14.62 | |
| Bank Of America Corporation warrant | 0.4 | $5.2M | 1.9M | 2.71 | |
| Dynavax Technologies Corporation | 0.3 | $3.7M | 2.0M | 1.86 | |
| Amicus Therapeutics (FOLD) | 0.3 | $3.8M | 983k | 3.84 | |
| iSoftStone Holdings | 0.2 | $2.1M | 325k | 6.49 | |
| Corcept Therapeutics Incorporated (CORT) | 0.1 | $1.7M | 559k | 3.10 | |
| Delcath Systems | 0.1 | $1.4M | 406k | 3.34 |
